Bicycle Therapeutics Cash from Financing (Quarterly) Insights

Bicycle Therapeutics PLC (BCYC)

21.38 -0.80 (-3.63%) USD | NASDAQ | May 17, 16:00

21.38 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	1.871M
December 31, 2023	0.386M
September 30, 2023	234.63M
June 30, 2023	12.29M
March 31, 2023	2.718M
December 31, 2022	5.888M
September 30, 2022	0.159M
June 30, 2022	0.195M
March 31, 2022	0.45M
December 31, 2021	190.66M
September 30, 2021	40.45M
June 30, 2021	15.55M
March 31, 2021	74.06M

Date	Value
December 31, 2020	1.744M
September 30, 2020	61.09M
June 30, 2020	0.01M
March 31, 2020	0.002M
December 31, 2019	0.122M
September 30, 2019	-0.811M
June 30, 2019	59.10M
March 31, 2019	0.034M
December 31, 2018	25.43M
September 30, 2018	0.001M
June 30, 2018	0.00
March 31, 2018	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.811M

Minimum

Sep 2019

234.63M

Maximum

Sep 2023

35.03M

Average

2.294M

Median

Cash from Financing (Quarterly) Benchmarks

Biodexa Pharmaceuticals Plc	--
NuCana PLC	-0.0533M
TC BioPharm (Holdings) PLC	--
Adaptimmune Therapeutics PLC	29.24M
Verona Pharma PLC	-3.123M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-70.87M
Cash from Investing (Quarterly)	-0.012M
Free Cash Flow	-85.93M
Free Cash Flow Per Share (Quarterly)	-1.665
Free Cash Flow to Equity (Quarterly)	-70.98M
Free Cash Flow to Firm (Quarterly)	-70.88M
Free Cash Flow Yield	-10.39%